SCHEMBL2145185

SCHEMBL2145185

O=CCN1CCc2cc(Nc3nc4cccc(-c5ccccc5)n4n3)ccc21

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 19/20 0.49
JAK3 P52333 17/20 0.49
PTK2 Q05397 16/20 0.49
JAK1 P23458 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2145124 0.81 SYK (0.55) JAK2JAK3PTK2JAK1
SCHEMBL2144495 0.74 JAK2 (0.52) JAK2JAK3PTK2JAK1
SCHEMBL3305387 0.73 JAK2 (0.52) JAK2JAK3PTK2JAK1
SCHEMBL13504378 0.72 JAK2 (0.51) JAK2JAK3PTK2JAK1
SCHEMBL2145239 0.72 JAK2 (0.49) JAK2JAK3PTK2JAK1
SCHEMBL2144480 0.72 JAK2 (0.64) JAK2JAK3PTK2JAK1
SCHEMBL2144170 0.72 JAK2 (0.48) JAK2JAK3PTK2JAK1
SCHEMBL2144842 0.71 JAK2 (0.48) JAK2JAK3PTK2JAK1
SCHEMBL13391135 0.70 JAK2 (0.51) JAK2JAK3PTK2JAK1
SCHEMBL3303044 0.70 JAK2 (0.77) JAK2JAK3PTK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344494-A1 AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS Signal Pharmaceuticals, LLC (US) 2011-07-20 EP claimed
WO-2010027500-A1 AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2010-03-11 WO claimed